Suppr超能文献

钙通道阻滞剂西尼地平可选择性抑制血管细胞中缺氧诱导因子1的活性。

The calcium channel blocker cilnidipine selectively suppresses hypoxia-inducible factor 1 activity in vascular cells.

作者信息

Oda Seiko, Oda Tomoyuki, Takabuchi Satoshi, Nishi Kenichiro, Wakamatsu Takuhiko, Tanaka Tomoharu, Adachi Takehiko, Fukuda Kazuhiko, Nohara Ryuji, Hirota Kiichi

机构信息

Department of Anesthesia, Kyoto University Hospital, Kyoto, Japan.

出版信息

Eur J Pharmacol. 2009 Mar 15;606(1-3):130-6. doi: 10.1016/j.ejphar.2009.01.012. Epub 2009 Jan 21.

Abstract

Calcium ion is one of the most important second messengers of cellular signal transduction including hypoxia-elicited signals. In this study, we investigated the effects of the L-type calcium channel blockers such as nifedipine, efonidipine cilnidipine, diltiazem, and verapamil, on the activity of hypoxia-inducible factor-1 (HIF-1), a key transcription factor in control of hypoxia-induced gene expression. Using the lung carcinoma cell line A549 cells, human aortic smooth muscle cells, and human umbilical vein endothelial cells, we demonstrated that cilnidipine exclusively suppressed HIF-1 activity and the expressions of downstream genes in a cell-type specific manner. We also demonstrated that cilnidipine blocked the synthesis of the HIF-1alpha protein not by affecting activity of the intracellular hypoxia-sensing element prolyl hydroxylases but inhibiting activity of Akt and mitogen-activated protein kinase and that the inhibition is not dependent on the effect on calcium homeostasis.

摘要

钙离子是细胞信号转导(包括缺氧引发的信号)中最重要的第二信使之一。在本研究中,我们研究了硝苯地平、依福地平、西尼地平、地尔硫䓬和维拉帕米等L型钙通道阻滞剂对缺氧诱导因子-1(HIF-1)活性的影响,HIF-1是控制缺氧诱导基因表达的关键转录因子。使用肺癌细胞系A549细胞、人主动脉平滑肌细胞和人脐静脉内皮细胞,我们证明西尼地平以细胞类型特异性方式专门抑制HIF-1活性和下游基因的表达。我们还证明,西尼地平不是通过影响细胞内缺氧传感元件脯氨酰羟化酶的活性,而是通过抑制Akt和丝裂原活化蛋白激酶的活性来阻断HIF-1α蛋白的合成,并且这种抑制不依赖于对钙稳态的影响。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验